Proposed Data Collections Submitted for Public Comment and Recommendations, 3048-3049 [E9-890]
Download as PDF
<![CDATA[
3048
Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices
telephone interview process with key
National Partners familiar with the
CPHP program. The categories of
questions will be similar to the CPHP
Interview Instrument to gather
information from the perspective of
National Partners. The CPHP State and
Local Partner/Customer Survey
Instrument will be used to gather
information from representatives of
organizations that have received
training or technical assistance from the
CPHP Program. It will be administered
electronically with an option for paper
copy administration. It is estimated that
there will be one request per respondent
and a total of 135 respondents with an
estimated time for data collection of 30
minutes. The CPHP Partner/Customer
Interview Instrument will be used to
gather more in-depth information on the
same categories of questions from the
Survey Instrument. It is estimated that
there will be a total of 54 respondents
with an estimated time for data
collection of 30 minutes.
There are no costs to respondents
except their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Pre-CPHP Interview Document Collection Protocol—CPHP staff ..
(2) CPHP Interview Instrument—CPHP staff ..................................
(3) CPHP National Partner Interview Instrument ............................
(4) CPHP State and Local Partner/Customer Survey Instrument ...
(5) CPHP State and Local Partner/Customer Interview Instrument
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Respondents
2
2
2
30/60
30/60
54
108
20
68
27
Total ..........................................................................................................................................................................................
277
Dated: January 8, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–889 Filed 1–15–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on PROD1PC66 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS-D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
19:02 Jan 15, 2009
Jkt 217001
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
[60 Day–09–09AL]
VerDate Nov<24>2008
27
54
10
135
54
The Green Housing Study—New—
National Center for Environmental
Health (NCEH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Green building principles and
practices have been shown to reduce
energy consumption, but their efficacy
in reducing environmental agents such
as pesticides, volatile organic
compounds (VOCs), fungi, and indoor
allergens is not clear. Furthermore, little
research has been conducted on health
impacts that might be related to green
buildings, especially on a nationwide
scale. Three main goals of this study are:
(1) To compare levels of certain
environmental chemical and biological
agents in green vs. traditional, multifamily, low-income housing; (2) to
ascertain differences in the health of the
residents in these homes; and (3) to
assess the economic impacts of the
‘‘greening’’ of housing-particularly those
related to health. These goals will be
accomplished in an ongoing building
renovation program, ‘‘Mark-to-Market’’
(M2M), sponsored by the Department of
Housing and Urban Development
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
1
1
1
1
1
Total burden
(in hours)
(HUD). Briefly, the M2M program is a
nationwide initiative that encourages
owners and purchasers of affordable,
multi-family properties to rehabilitate
and operate their properties using
sustainable green building principles. In
partnership with HUD, the CDC will
leverage this opportunity to collect
survey and biomarker data from
residents and to collect environmental
measurements in their homes in order to
evaluate associations between green
housing and health.
This study directly supports the
Healthy Homes’ health protection goal
of the Centers for Disease Control and
Prevention (CDC). This investigation is
also consistent with CDC’s Health
Protection Research Agenda, which
calls for research to identify the major
environmental causes of disease and
disability and related risk factors.
Indoor allergens such as those from
cockroaches, dust mites, mice, and fungi
have been associated with childhood
asthma. Also, VOCs and pesticides have
been associated with adverse birth
outcomes (e.g., low birth weight and
prematurity) and delayed
neurodevelopment. Given that green
principles such as improvement of
ventilation systems and elimination of
spray pesticides can directly affect the
concentrations of chemical and
biological agents in air, residents in
green housing should theoretically have
better health outcomes (e.g., asthma,
birth outcomes, and infant
neurodevelopment, this in turn will
lead to lower healthcare utilization and
overall societal costs.
Participants will include pregnant
women, mothers and children living in
E:\FR\FM\16JAN1.SGM
16JAN1
3049
Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices
HUD-subsidized housing that has either
been rehabilitated in a green (e.g., case)
or a traditional manner (e.g., control)
from study sites across the United
States. Pregnant women and children
with asthma (ages 7–12 years) will
donate blood samples (for assessment of
allergy) and urine samples (for
assessment of pesticide and VOC
exposures). The children with asthma
(ages 7–12 years) will be also tested for
lung function and lung inflammatory
markers. Questionnaires regarding home
characteristics and respiratory
symptoms will be administered at 3month intervals over a 2-year period. Of
the pregnant women enrolled,
neurodevelopment of their infant will
be tested at ages 1 week and 6 months.
Environmental sampling of the air and
dust in the participants’ homes will be
conducted over a 2 year period (once in
the home before rehabilitation, and then
at four time points after rehabilitation
has been completed: Baseline, 6 months,
12 months, and 24 months).
Environmental sampling includes
measurements of air exchange rate,
pesticides, VOCs, indoor allergens,
fungi, temperature, humidity, and
particulate matter.
There is no cost to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
Mothers of enrolled
children.
Number of
responses per
respondent
Number of
respondents
Forms
Average burden
per response
(in hours)
Total burden
(in hours)
Screening questionnaire ............................
800
1
5/60
067
Baseline Questionnaire (Home Characteristics).
Baseline Questionnaire (for Mother) .........
Baseline Questionnaire (for Children 0–6
years).
Baseline Questionnaire (for Children 7–12
with asthma).
3, 9, 15, and 18-month Phone contact .....
6, 12, and 24-month Follow-up Questionnaire (for environment).
6, 12, and 24-month Follow-up Questionnaire (for women).
6, 12, and 24-month Follow-up Questionnaire (for children 0–6).
6, 12, and 24-month Follow-up Questionnaire (for asthmatic child 7–12).
Screening questionnaire ............................
Baseline Questionnaire (Home Characteristics).
Baseline Questionnaire (for Pregnant
woman).
3, 9, 15, and 18-month Phone contact .....
6, 12, and 24-month Follow-up Questionnaire (for environment).
6, 12, and 24-month Follow-up Questionnaire (for women).
Post-delivery questionnaire .......................
688
1
15/60
172
688
688
1
1
15/60
15/60
172
172
688
1
15/60
172
688
688
4
3
5/60
10/60
229
344
688
3
10/60
344
688
3
10/60
344
688
3
10/60
344
800
688
1
1
5/60
15/60
67
172
688
1
15/60
172
688
688
4
3
5/60
10/60
229
344
688
3
10/60
344
688
1
5/60
57
Total ..........................................................................................................................................................................................
3745
Pregnant women .....
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
mstockstill on PROD1PC66 with NOTICES
Dated: January 8, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–890 Filed 1–15–09; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Member
Conflict Review, Program
Announcement (PA) 07–318
Centers for Disease Control and
Prevention
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 1 p.m.–3 p.m., March 5,
2009 (Closed).
Place: National Institute for Occupational
Safety and Health (NIOSH), CDC, 1095
VerDate Nov<24>2008
19:02 Jan 15, 2009
Jkt 217001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Willowdale Road, Morgantown, West
Virginia 26506, telephone: (304) 285–6143.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Member Conflict Review, PA
07–318.’’
Contact Person for More Information: Chris
Langub, PhD, Scientific Review Official,
NIOSH, CDC, 2400 Century Center, Atlanta,
GA 30333, telephone: (404) 498–2543.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
E:\FR\FM\16JAN1.SGM
16JAN1
]]>Agencies
[Federal Register Volume 74, Number 11 (Friday, January 16, 2009)]
[Notices]
[Pages 3048-3049]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-890]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-09-09AL]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
The Green Housing Study--New--National Center for Environmental
Health (NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Green building principles and practices have been shown to reduce
energy consumption, but their efficacy in reducing environmental agents
such as pesticides, volatile organic compounds (VOCs), fungi, and
indoor allergens is not clear. Furthermore, little research has been
conducted on health impacts that might be related to green buildings,
especially on a nationwide scale. Three main goals of this study are:
(1) To compare levels of certain environmental chemical and biological
agents in green vs. traditional, multi-family, low-income housing; (2)
to ascertain differences in the health of the residents in these homes;
and (3) to assess the economic impacts of the ``greening'' of housing-
particularly those related to health. These goals will be accomplished
in an ongoing building renovation program, ``Mark-to-Market'' (M2M),
sponsored by the Department of Housing and Urban Development (HUD).
Briefly, the M2M program is a nationwide initiative that encourages
owners and purchasers of affordable, multi-family properties to
rehabilitate and operate their properties using sustainable green
building principles. In partnership with HUD, the CDC will leverage
this opportunity to collect survey and biomarker data from residents
and to collect environmental measurements in their homes in order to
evaluate associations between green housing and health.
This study directly supports the Healthy Homes' health protection
goal of the Centers for Disease Control and Prevention (CDC). This
investigation is also consistent with CDC's Health Protection Research
Agenda, which calls for research to identify the major environmental
causes of disease and disability and related risk factors.
Indoor allergens such as those from cockroaches, dust mites, mice,
and fungi have been associated with childhood asthma. Also, VOCs and
pesticides have been associated with adverse birth outcomes (e.g., low
birth weight and prematurity) and delayed neurodevelopment. Given that
green principles such as improvement of ventilation systems and
elimination of spray pesticides can directly affect the concentrations
of chemical and biological agents in air, residents in green housing
should theoretically have better health outcomes (e.g., asthma, birth
outcomes, and infant neurodevelopment, this in turn will lead to lower
healthcare utilization and overall societal costs.
Participants will include pregnant women, mothers and children
living in
[[Page 3049]]
HUD-subsidized housing that has either been rehabilitated in a green
(e.g., case) or a traditional manner (e.g., control) from study sites
across the United States. Pregnant women and children with asthma (ages
7-12 years) will donate blood samples (for assessment of allergy) and
urine samples (for assessment of pesticide and VOC exposures). The
children with asthma (ages 7-12 years) will be also tested for lung
function and lung inflammatory markers. Questionnaires regarding home
characteristics and respiratory symptoms will be administered at 3-
month intervals over a 2-year period. Of the pregnant women enrolled,
neurodevelopment of their infant will be tested at ages 1 week and 6
months. Environmental sampling of the air and dust in the participants'
homes will be conducted over a 2 year period (once in the home before
rehabilitation, and then at four time points after rehabilitation has
been completed: Baseline, 6 months, 12 months, and 24 months).
Environmental sampling includes measurements of air exchange rate,
pesticides, VOCs, indoor allergens, fungi, temperature, humidity, and
particulate matter.
There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Forms Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Mothers of enrolled children............... Screening questionnaire............ 800 1 5/60 067
Baseline Questionnaire (Home 688 1 15/60 172
Characteristics).
Baseline Questionnaire (for Mother) 688 1 15/60 172
Baseline Questionnaire (for 688 1 15/60 172
Children 0-6 years).
Baseline Questionnaire (for 688 1 15/60 172
Children 7-12 with asthma).
3, 9, 15, and 18-month Phone 688 4 5/60 229
contact.
6, 12, and 24-month Follow-up 688 3 10/60 344
Questionnaire (for environment).
6, 12, and 24-month Follow-up 688 3 10/60 344
Questionnaire (for women).
6, 12, and 24-month Follow-up 688 3 10/60 344
Questionnaire (for children 0-6).
6, 12, and 24-month Follow-up 688 3 10/60 344
Questionnaire (for asthmatic child
7-12).
Pregnant women............................. Screening questionnaire............ 800 1 5/60 67
Baseline Questionnaire (Home 688 1 15/60 172
Characteristics).
Baseline Questionnaire (for 688 1 15/60 172
Pregnant woman).
3, 9, 15, and 18-month Phone 688 4 5/60 229
contact.
6, 12, and 24-month Follow-up 688 3 10/60 344
Questionnaire (for environment).
6, 12, and 24-month Follow-up 688 3 10/60 344
Questionnaire (for women).
Post-delivery questionnaire........ 688 1 5/60 57
------------------------------------------------------------------------------------------------------------
Total............................................................................................................................. 3745
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: January 8, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-890 Filed 1-15-09; 8:45 am]
BILLING CODE 4163-18-P
